Crohn's disease associated with inferferon and ribavirin treatment for chronic hepatitis C;Maladie de Crohn au cours du traitement de l'hépatite chronique C par interféron et ribavirine

Gastroenterologie Clinique et Biologique

Volumn 29, Issue 2, 2005, Pages 193-196

  Khalil, Ali ^a   Lucidarme, Damien ^a   Desurmont, Philippe ^b   Hamdan Khalil, Rima ^c   Filoche, Bernard ^a  

^a Centre Hospitalier Saint Philibert GHICL   (France)

^b Cabinet de Gastro entérologie   (France)

^c UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; CORTICOSTEROID; INTERFERON; MESALAZINE; PEGINTERFERON; RIBAVIRIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COLITIS; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; FEMALE; HEPATITIS C; HUMAN; IMMUNOMODULATION; MALE; TREATMENT OUTCOME;

EID: 15244346943     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-8320(05)80736-5     Document Type: Article

References (24)

1. Fattovich G, Giustina G, Favarato S, Ruol A. À survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 1996;24:38-47.
2. Conférence de consensus. Traitement de l'hépatite C. Texte de Consensus. Gastroenterol Clin Biol 2002;26:303-11.
3. Vial T, Bailly F, Descotes J, Trepo C. Effets secondaires de l'interféron alpha. Gastroenterol Clin Biol 1996;20:462-89.
4. Dusheiko G. Side effects of alpha interferon in chronic hepatitis C. Hepatology 1997;26:112-21.
5. Tada H, Saitoh S, Nakagawa Y, Hirana H, Morimoto M, Shima T, et al. Ischemic colitis during interferon-alpha treatment for chronic active hepatitis C. J Gastroenterol 1996;31:582-4.
6. Wazaz HM, Arce DG, Sack DM. Ischemic colitis during treatment of hepatitis C with interferon-ribavirin combination therapy. Am J Gastroenterol 2001;96:253-4.
7. Wenner WJ, Piccoli DA. Colitis associated with alpha interferon. J Clin Gastroenterol 1997;25:398-99.
8. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20:15-20.
9. Shanahan F. Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 2001;120:622-35.
10. Shanahan F. Crohn's disease. Lancet 2002;359:62-9.
11. Dumoulin FL, Leifeld L, Sauerbruch T, Spengler U. Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis. Biomed Pharmacother 1999;53:242-54.
12. Revel M. The Genetic and functional diversity of interferons in man. Interferon 1983;5:205-39.
13. Adinolfi LE, Durante Mangoni E, Andreana A. Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease. Am J Gastroenterol 2001;96:607-8.
14. Cammarota G, Cuoco L, Cianci R, Pandolfi F, Gasbarrini G. Onset of coeliac disease during treatment with interferon for chronic hepatitis C. Lancet 2000 28;356:1494-5.
15. Biacone L, Pavia M, Del vecchio Blanco G, D'Inca R, Castiglione F, Nigris F, et al. Hepatitis B and C virus infection in Crohn's disease. Inflamm Bowel Dis 2001;7:287-94.
16. Ruther U, Nunnensiek C, Muller HA, Bader H, May U, Jipp P. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease). Hepatogastroenterology 1998;45:691-9.
17. Pariente A, Liversain JM, Briaud M, Texereau P. Rémission prolongée d'une hépatite chronique C malgré un traitement corticoïde et immusuppresseur. Gastroenterol Clin Biol 1997;21:635.
18. Sumer N, Palabiyikoglu M. Induction of remission by interferon-alpha in patients with chronic active ulcerative colitis. Eur J Gastroenterol Hepatol 1995;7:597-602.
19. Madsen SM, Schlichting P, Davidsen B, Nielsen OH, Federspiel B, Riis P, et al. An open-labeled, randomized study comparing systemic interferon-alpha-2A and prednisolone enemas in the treatment of left-sided ulcerative colitis. Am J Gastroenterol 2001;96:1807-15.
20. Tilg H, Vogelsang H, Ludwiczek O, Lochs H, Kaser A, Colombel JF, et al. À randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis. Gut 2003;52:1728-33.
21. Mavrogiannis C, Papanikolaou IS, Elefsiniotis IS, Psilopoulos DI, Karameris A, Karvountzis G. Ulcerative colitis associated with interferon treatment for chronic hepatitis C. J Hepatol 2001;34:964-5.
22. Mitoro A, Yoshikawa M, Yamamoto K, Mimura M, Yoshikawa Y, Shiroi A, et al. Exacerbation of ulcerative colitis during alpha-interferon therapy for chronic hepatitis C. Intern Med 1993;32:327-31.
23. William J, Wenner JR, David A, Piccoli MD. Colitis associated with alpha interferon. J Gastroenterol 1997;25:398-9.
24. Ben-sagheer ST, Avalos ME. Interferon alpha induced acute colitis in a patient with hepatitis C. Am J Gastroenterol 2001;96:182.